Automated screening of COVID-19 preprints: can we help authors to improve transparency and reproducibility?
作者信息
Weissgerber Tracey, Riedel Nico, Kilicoglu Halil, Labbé Cyril, Eckmann Peter, Ter Riet Gerben, Byrne Jennifer, Cabanac Guillaume, Capes-Davis Amanda, Favier Bertrand, Saladi Shyam, Grabitz Peter, Bannach-Brown Alexandra, Schulz Robert, McCann Sarah, Bernard Rene, Bandrowski Anita
机构信息
Quality | Ethics | Open Science | Translation (QUEST), Berlin Institute of Health, Berlin, Germany.
Charité-Universitätsmedizin Berlin, Berlin, Germany.
出版信息
Nat Med. 2021 Jan;27(1):6-7. doi: 10.1038/s41591-020-01203-7.
Abstract
摘要
相似文献
1
Automated screening of COVID-19 preprints: can we help authors to improve transparency and reproducibility?新冠疫情预印本的自动化筛选：我们能否帮助作者提高透明度和可重复性？
Nat Med. 2021 Jan;27(1):6-7. doi: 10.1038/s41591-020-01203-7.
2
Rise of the Rxivs: How Preprint Servers are Changing the Publishing Process.预印本服务器的兴起：预印本服务器如何改变出版流程。
Med Ref Serv Q. 2020 Jan-Mar;39(1):84-89. doi: 10.1080/02763869.2020.1704597.
3
The development of preprints during the COVID-19 pandemic.新冠疫情期间预印本的发展。
J Intern Med. 2021 Aug;290(2):480-483. doi: 10.1111/joim.13240. Epub 2021 Feb 9.
4
The perils of preprints.预印本的风险。
BMJ. 2020 Aug 17;370:m3111. doi: 10.1136/bmj.m3111.
5
The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape.预印本在 COVID-19 研究传播中的作用演变及其对科学传播格局的影响。
PLoS Biol. 2021 Apr 2;19(4):e3000959. doi: 10.1371/journal.pbio.3000959. eCollection 2021 Apr.
6
Preprints and Cardiovascular Science: Prescient or Premature?预印本与心血管科学：有先见之明还是为时过早？
Circulation. 2017 Sep 26;136(13):1177-1179. doi: 10.1161/CIRCULATIONAHA.117.031238. Epub 2017 Sep 14.
7
Flawed ivermectin preprint highlights challenges of COVID drug studies.有缺陷的伊维菌素预印本凸显了新冠药物研究的挑战。
Nature. 2021 Aug;596(7871):173-174. doi: 10.1038/d41586-021-02081-w.
8
How a torrent of COVID science changed research publishing - in seven charts.新冠科学洪流如何改变研究出版——用七张图表展示
Nature. 2020 Dec;588(7839):553. doi: 10.1038/d41586-020-03564-y.
9
Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic.关于 COVID-19 大流行的学术出版物、预印本和注册临床试验的特征。
PLoS One. 2020 Oct 6;15(10):e0240123. doi: 10.1371/journal.pone.0240123. eCollection 2020.
10
Rigorous review and editorial oversight of clinical preprints.严格审查和编辑监督临床预印本。
Elife. 2021 Jun 16;10:e67528. doi: 10.7554/eLife.67528.
引用本文的文献
1
Building a synthesis-ready research ecosystem: fostering collaboration and open science to accelerate biomedical translation.构建一个可供综合研究的生态系统：促进合作与开放科学以加速生物医学转化。
BMC Med Res Methodol. 2025 Mar 10;25(1):66. doi: 10.1186/s12874-025-02524-2.
2
SPIRIT-CONSORT-TM: a corpus for assessing transparency of clinical trial protocol and results publications.SPIRIT-CONSORT-TM：一个用于评估临床试验方案和结果出版物透明度的语料库。
Sci Data. 2025 Feb 28;12(1):355. doi: 10.1038/s41597-025-04629-1.
3
Improving research transparency with individualized report cards: A feasibility study in clinical trials at a large university medical center.使用个性化报告卡提高研究透明度：大型大学医学中心临床试验的可行性研究。
BMC Med Res Methodol. 2025 Feb 13;25(1):37. doi: 10.1186/s12874-025-02482-9.
4
SPIRIT-CONSORT-TM: a corpus for assessing transparency of clinical trial protocol and results publications.SPIRIT-CONSORT-TM：一个用于评估临床试验方案和结果出版物透明度的语料库。
medRxiv. 2025 Jan 15:2025.01.14.25320543. doi: 10.1101/2025.01.14.25320543.
5
Text classification models for assessing the completeness of randomized controlled trial publications based on CONSORT reporting guidelines.基于 CONSORT 报告规范的评估随机对照试验出版物完整性的文本分类模型。
Sci Rep. 2024 Sep 17;14(1):21721. doi: 10.1038/s41598-024-72130-7.
6
Using an expert survey and user feedback to construct PRECHECK: A checklist to evaluate preprints on COVID-19 and beyond.利用专家调查和用户反馈来构建 PRECHECK：一个评估 COVID-19 及其他预印本的清单。
F1000Res. 2024 Jun 3;12:588. doi: 10.12688/f1000research.129814.3. eCollection 2023.
7
CONSORT-TM: Text classification models for assessing the completeness of randomized controlled trial publications.CONSORT-TM：用于评估随机对照试验出版物完整性的文本分类模型。
medRxiv. 2024 Apr 1:2024.03.31.24305138. doi: 10.1101/2024.03.31.24305138.
8
Automatic categorization of self-acknowledged limitations in randomized controlled trial publications.自我承认的随机对照试验出版物局限性的自动分类。
J Biomed Inform. 2024 Apr;152:104628. doi: 10.1016/j.jbi.2024.104628. Epub 2024 Mar 26.
9
Retrieval augmented scientific claim verification.检索增强型科学声明验证
JAMIA Open. 2024 Feb 21;7(1):ooae021. doi: 10.1093/jamiaopen/ooae021. eCollection 2024 Apr.
10
Limiting open science? Three approaches to bottom-up governance of dual-use research of concern.限制开放科学？关注两用研究自下而上治理的三种方法。
Pathog Glob Health. 2024 Jun;118(4):285-294. doi: 10.1080/20477724.2023.2265626. Epub 2023 Oct 4.
本文引用的文献
1
The Rigor and Transparency Index Quality Metric for Assessing Biological and Medical Science Methods.用于评估生物医学科学方法的严谨性与透明度指数质量指标
iScience. 2020 Oct 20;23(11):101698. doi: 10.1016/j.isci.2020.101698. eCollection 2020 Nov 20.
2
Will the pandemic permanently alter scientific publishing?这场大流行会永久性地改变科学出版吗？
Nature. 2020 Jun;582(7811):167-168. doi: 10.1038/d41586-020-01520-4.
3
COVID-19: the gendered impacts of the outbreak.新冠疫情：疫情爆发对性别的影响
Lancet. 2020 Mar 14;395(10227):846-848. doi: 10.1016/S0140-6736(20)30526-2. Epub 2020 Mar 6.
4
Reveal, Don't Conceal: Transforming Data Visualization to Improve Transparency.揭示，而非隐藏：转变数据可视化以提升透明度。
Circulation. 2019 Oct 29;140(18):1506-1518. doi: 10.1161/CIRCULATIONAHA.118.037777. Epub 2019 Oct 28.
5
Semi-automated fact-checking of nucleotide sequence reagents in biomedical research publications: The Seek & Blastn tool.生物医学研究出版物中核苷酸序列试剂的半自动事实核查：Seek & Blastn 工具。
PLoS One. 2019 Mar 1;14(3):e0213266. doi: 10.1371/journal.pone.0213266. eCollection 2019.
6
Automatic recognition of self-acknowledged limitations in clinical research literature.临床研究文献中自我承认局限性的自动识别。
J Am Med Inform Assoc. 2018 Jul 1;25(7):855-861. doi: 10.1093/jamia/ocy038.
7
Recombinant DNA research: proposed actions under guidelines.重组DNA研究：指南下的拟议行动
Fed Regist. 1984 Sep 20;49(184):37016-7.
Zotero 插件